First-in-class radio-theranostic utilizes novel antibody to target B7-H3 proteins in cancer cells

byUniversity of Texas MD Anderson Cancer CenterDevelopment of a high affinity, 4Ig-isoform selective antibody for beta-radioligand therapy. Credit:Theranostics(2026). DOI: 10.7150/thno.123285Researche

Updated on: June 20,2026

First-in-class radio-theranostic utilizes novel antibody to target B7-H3 proteins in cancer cells

byUniversity of Texas MD Anderson Cancer CenterDevelopment of a high affinity, 4Ig-isoform selective antibody for beta-radioligand therapy. Credit:Theranostics(2026). DOI: 10.7150/thno.123285Researche

Updated on:June 20,2026

Strongest evidence yet that vaping likely causes cancer

by Bernard Stewart,The ConversationCredit: Unsplash/CC0 Public DomainAs early as the 1880s,there was evidencethat smoking tobacco damaged your lungs. But it took almost 100 years todefinitively showth

Updated on: June 20,2026

Strongest evidence yet that vaping likely causes cancer

by Bernard Stewart,The ConversationCredit: Unsplash/CC0 Public DomainAs early as the 1880s,there was evidencethat smoking tobacco damaged your lungs. But it took almost 100 years todefinitively showth

Updated on:June 20,2026

Cancer risk rises with autoimmune disorders but drops after anti-inflammatory therapy, finds study

by Sbarro Health Research Organization (SHRO)Credit: Pixabay/CC0 Public DomainWhen patients start getting treated for conditions like psoriatic arthritis, or connective tissue diseases like lupus and

Updated on: June 19,2026

Cancer risk rises with autoimmune disorders but drops after anti-inflammatory therapy, finds study

by Sbarro Health Research Organization (SHRO)Credit: Pixabay/CC0 Public DomainWhen patients start getting treated for conditions like psoriatic arthritis, or connective tissue diseases like lupus and

Updated on:June 19,2026

Genetic variants involved in rapid immune response linked to earlier breast cancer onset in BRCA1 carriers

byBritish Medical JournalCredit: CC0 Public DomainDamaging variants in genes involved in a rapid immune response (innate immunity) are significantly linked to earlier breast cancer onset in carriers o

Updated on: May 24,2026

Genetic variants involved in rapid immune response linked to earlier breast cancer onset in BRCA1 carriers

byBritish Medical JournalCredit: CC0 Public DomainDamaging variants in genes involved in a rapid immune response (innate immunity) are significantly linked to earlier breast cancer onset in carriers o

Updated on:May 24,2026

Surgeon highlights breast cancer screening challenges for women with dense breast tissue

by Uniformed Services University of the Health Sciences (USU)Credit: Unsplash/CC0 Public DomainA new editorial by a Uniformed Services University (USU) faculty member calls attention to challenges in

Updated on: June 11,2026

Surgeon highlights breast cancer screening challenges for women with dense breast tissue

by Uniformed Services University of the Health Sciences (USU)Credit: Unsplash/CC0 Public DomainA new editorial by a Uniformed Services University (USU) faculty member calls attention to challenges in

Updated on:June 11,2026

Researchers identify new target to counteract muscle wasting in pancreatic cancer

by Laurie Fickman,University of HoustonSynopsis. Credit:EMBO Molecular Medicine(2025). DOI: 10.1038/s44321-025-00337-wResearchers at the University of Houston are pushing the boundaries of biomedical

Updated on: March 30,2026

Researchers identify new target to counteract muscle wasting in pancreatic cancer

by Laurie Fickman,University of HoustonSynopsis. Credit:EMBO Molecular Medicine(2025). DOI: 10.1038/s44321-025-00337-wResearchers at the University of Houston are pushing the boundaries of biomedical

Updated on:March 30,2026

Dangers of 'anti-aging' supplements in cancer protection revealed

byCase Western Reserve UniversityGraphical abstract. Credit:Cancer Letters(2026). DOI: 10.1016/j.canlet.2026.218334Millions of Americans take daily supplements—nicotinamide mononucleotide (NMN), nicot

Updated on: June 15,2026

Dangers of 'anti-aging' supplements in cancer protection revealed

byCase Western Reserve UniversityGraphical abstract. Credit:Cancer Letters(2026). DOI: 10.1016/j.canlet.2026.218334Millions of Americans take daily supplements—nicotinamide mononucleotide (NMN), nicot

Updated on:June 15,2026

A new immunotherapy target? How SRC-3 in Tregs may reshape solid-tumor treatment

by Ana María Rodríguez,Baylor College of MedicineThe loss of SRC-3 in Treg leads to immune suppression of glioblastoma in mice: (A) Experimental design for the orthotopic injection of glioblastoma cel

Updated on: May 23,2026

A new immunotherapy target? How SRC-3 in Tregs may reshape solid-tumor treatment

by Ana María Rodríguez,Baylor College of MedicineThe loss of SRC-3 in Treg leads to immune suppression of glioblastoma in mice: (A) Experimental design for the orthotopic injection of glioblastoma cel

Updated on:May 23,2026

Rearranging tumor cell structures—new approach could treat cancer

by Tim Tedeschi,University of CincinnatiBiomedical research typically follows a familiar path: developing treatments that block, enhance or mutate certain signaling pathways, genes or proteins to chan

Updated on: March 28,2026

Rearranging tumor cell structures—new approach could treat cancer

by Tim Tedeschi,University of CincinnatiBiomedical research typically follows a familiar path: developing treatments that block, enhance or mutate certain signaling pathways, genes or proteins to chan

Updated on:March 28,2026

Researchers demonstrate breakthroughs in cancer treatment quality through AI-enhanced data analytics

byUniversity of Tennessee at KnoxvilleSpatial clusters of the top six county-level features influencing LC mortality predictions using Getis-ord Gi. Credit:JCO Clinical Cancer Informatics(2025). DOI:

Updated on: March 29,2026

Researchers demonstrate breakthroughs in cancer treatment quality through AI-enhanced data analytics

byUniversity of Tennessee at KnoxvilleSpatial clusters of the top six county-level features influencing LC mortality predictions using Getis-ord Gi. Credit:JCO Clinical Cancer Informatics(2025). DOI:

Updated on:March 29,2026

Why some cancer therapies don't work for all patients: A tumor backup survival pathway

by Anne Trafton,Massachusetts Institute of TechnologyMany of the targeted tumors turn on a backup survival pathway that helps them keep growing when tyrosine kinase—pictured here as strands—is turned

Updated on: May 26,2026

Why some cancer therapies don't work for all patients: A tumor backup survival pathway

by Anne Trafton,Massachusetts Institute of TechnologyMany of the targeted tumors turn on a backup survival pathway that helps them keep growing when tyrosine kinase—pictured here as strands—is turned

Updated on:May 26,2026

PSMA therapy delays hormone therapy in prostate cancer, clinical trial finds

byRadboud UniversityNuclear medicine physician James Nagarajah from Radboudumc in the clinics. Credit: RadboudumcWhere previous research showed that PSMA therapy for prostate cancer can prolong the li

Updated on: May 25,2026

PSMA therapy delays hormone therapy in prostate cancer, clinical trial finds

byRadboud UniversityNuclear medicine physician James Nagarajah from Radboudumc in the clinics. Credit: RadboudumcWhere previous research showed that PSMA therapy for prostate cancer can prolong the li

Updated on:May 25,2026